Evidence map›Paper›PMID 35653398›Full record

ArticlePLoS genetics2022

Evolutionarily stable gene clusters shed light on the common grounds of pathogenicity in the Acinetobacter calcoaceticus-baumannii complex.

Bardya Djahanschiri, Gisela Di Venanzio, Jesus S Distel, Jennifer Breisch, Marius Alfred Dieckmann, Alexander Goesmann, Beate Averhoff, Stephan Göttig, Gottfried Wilharm, Mario F Feldman and 1 more

Abstract read
In one paragraph

Article in PLoS genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. AnResearch square · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Genomic Characterization of a Carbapenem-ResistantPathogens (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. The fitness connection of antibiotic resistance.Frontiers in microbiology · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bardya DjahanschiriApplied Bioinformatics Group, Inst. of Cell Biology and Neuroscience, Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID 0000-0002-6066-8315
Gisela Di VenanzioDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, Missouri, United States of America.ORCID 0000-0003-1969-3145
Jesus S DistelDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, Missouri, United States of America.ORCID 0000-0003-4589-5314
Jennifer BreischInst. of Molecular Biosciences, Department of Molecular Microbiology and Bioenergetics, Goethe University Frankfurt, Frankfurt am Main, Germany.
Marius Alfred DieckmannBioinformatics and Systems Biology, Justus Liebig University Gießen, Gießen, Germany.ORCID 0000-0001-5130-546X
Alexander GoesmannBioinformatics and Systems Biology, Justus Liebig University Gießen, Gießen, Germany.ORCID 0000-0002-7086-2568
Beate AverhoffInst. of Molecular Biosciences, Department of Molecular Microbiology and Bioenergetics, Goethe University Frankfurt, Frankfurt am Main, Germany.
Stephan GöttigInstitute for Medical Microbiology and Infection Control, University Hospital, Goethe University, Frankfurt, Germany.ORCID 0000-0001-6896-5309
Gottfried WilharmRobert Koch Institute, Project group P2, Wernigerode, Germany.ORCID 0000-0002-1771-6799
Mario F FeldmanDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, Missouri, United States of America.ORCID 0000-0003-4497-0976
Ingo EbersbergerApplied Bioinformatics Group, Inst. of Cell Biology and Neuroscience, Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID 0000-0001-8187-9253

Funding

Molecular Insights into the Uropathogenesis of MDR Acinetobacter baumanniiR01AI144120 · NIAID · WASHINGTON UNIVERSITY · PI Mario Feldman · 2019 to 2026
$4.1M
NIAID NIH HHS R01 AI144120
6 · The paper itself

Abstract

Nosocomial pathogens of the Acinetobacter calcoaceticus-baumannii (ACB) complex are a cautionary example for the world-wide spread of multi- and pan-drug resistant bacteria. Aiding the urgent demand for novel therapeutic targets, comparative genomics studies between pathogens and their apathogenic relatives shed light on the genetic basis of human-pathogen interaction. Yet, existing studies are limited in taxonomic scope, sensing of the phylogenetic signal, and resolution by largely analyzing genes independent of their organization in functional gene clusters. Here, we explored more than 3,000 Acinetobacter genomes in a phylogenomic framework integrating orthology-based phylogenetic profiling and microsynteny conservation analyses. We delineate gene clusters in the type strain A. baumannii ATCC 19606 whose evolutionary conservation indicates a functional integration of the subsumed genes. These evolutionarily stable gene clusters (ESGCs) reveal metabolic pathways, transcriptional regulators residing next to their targets but also tie together sub-clusters with distinct functions to form higher-order functional modules. We shortlisted 150 ESGCs that either co-emerged with the pathogenic ACB clade or are preferentially found therein. They provide a high-resolution picture of genetic and functional changes that coincide with the manifestation of the pathogenic phenotype in the ACB clade. Key innovations are the remodeling of the regulatory-effector cascade connecting LuxR/LuxI quorum sensing via an intermediate messenger to biofilm formation, the extension of micronutrient scavenging systems, and the increase of metabolic flexibility by exploiting carbon sources that are provided by the human host. We could show experimentally that only members of the ACB clade use kynurenine as a sole carbon and energy source, a substance produced by humans to fine-tune the antimicrobial innate immune response. In summary, this study provides a rich and unbiased set of novel testable hypotheses on how pathogenic Acinetobacter interact with and ultimately infect their human host. It is a comprehensive resource for future research into novel therapeutic strategies.

Indexed as

Acinetobacter calcoaceticusAcinetobacter InfectionsCarbonHumansMultigene FamilyPhylogenyVirulenceCarbon

Identifiers

PMID35653398
PMCPMC9162365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.